Pazoo (PZOO) YoY EBITDA Growth: 109.09% (As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pazoo YoY EBITDA Growth?

Pazoo PZOO -90.00% YoY EBITDA Growth is 109.09% as of Dec. 2017.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pazoo's YoY EBITDA Growth for the quarter that ended in Dec. 2017 was 109.09%.

Pazoo's EBITDA per Share for the three months ended in Dec. 2017 was $0.00.


Pazoo YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Pazoo's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pazoo YoY EBITDA Growth Chart

Pazoo Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
YoY EBITDA Growth
Get a 7-Day Free Trial 72.25 -283.34 89.99 97.49 99.15

Pazoo Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.95 99.66 100.01 -108.95 109.09

Pazoo YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pazoo's YoY EBITDA Growth for the fiscal year that ended in Dec. 2017 is calculated as:

YoY EBITDA Growth (A: Dec. 2017 )
=(EBITDA per Share (A: Dec. 2017 )-EBITDA per Share (A: Dec. 2016 ))/ | EBITDA per Share (A: Dec. 2016 ) |
=(-0.018--2.112)/ | -2.112 |
=99.15 %

Pazoo's YoY EBITDA Growth for the quarter that ended in Dec. 2017 is calculated as:

YoY EBITDA Growth (Q: Dec. 2017 )
=(EBITDA per Share (Q: Dec. 2017 )-EBITDA per Share (Q: Dec. 2016 )) / | EBITDA per Share (Q: Dec. 2016 )) |
=(0.001--0.011)/ | -0.011 |
=109.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 109.09% mean?
Pazoo (PZOO) has a YoY EBITDA Growth of 109.09% as of Dec. 2017. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Pazoo and its competitors.
Is Pazoo's YoY EBITDA Growth too high?
Pazoo's current YoY EBITDA Growth is 109.09%.
How does Pazoo's YoY EBITDA Growth compare to LKST and IDDR?
Pazoo's YoY EBITDA Growth of 109.09% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Pazoo and its competitors. Pazoo's current YoY EBITDA Growth is 109.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pazoo stock overvalued right now?
Pazoo (PZOO) has a current YoY EBITDA Growth of 109.09%. The current YoY EBITDA Growth is 109.09%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Pazoo (PZOO), the current YoY EBITDA Growth is 109.09% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pazoo Business Description

Address 34 DeForest Road, Unit 9, East Hanover, NJ, USA, 07936
Pazoo Inc is focused on health, wellness, and safety. The company's focus is to provide laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants, and other irregularities.